TABLE OF CONTENTS
1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.3 OVERVIEW OF GLOBAL BREAST IMPLANTS MARKET 22
1.4 LIMITATIONS 24
1.5 MARKETS COVERED 24
2 MARKET SEGMENTATION 26
2.1 MARKETS COVERED 26
2.2 GLOBAL BREAST IMPLANTS MARKET: GEOGRAPHICAL SCOPE 27
2.3 YEARS CONSIDERED FOR THE STUDY 28
2.4 CURRENCY AND PRICING 28
2.5 DBMR TRIPOD DATA VALIDATION MODEL 29
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 32
2.7 DBMR MARKET POSITION GRID 33
2.8 DBMR VENDOR SHARE ANALYSIS 34
2.9 MULTIVARIATE MODELING 35
2.10 PRODUCTS LIFELINE CURVE 35
2.11 SECONDARY SOURCES 36
2.12 ASSUMPTIONS 36
3 EXECUTIVE SUMMARY 37
4 MARKET OVERVIEW 40
4.1 DRIVERS 42
4.1.1 INCREASING PREVALENCE OF BREAST CANCER 42
4.1.2 GROWING AWARENESS TOWARDS RESTORATION OPTIONS 43
4.1.3 TECHNOLOGICAL ADVANCES AND IMPROVEMENTS 44
4.2 RESTRAINTS 45
4.2.1 HIGH PROCEDURAL COSTS 45
4.2.2 THE RISK FOR RE-SURGERY OF THE IMPLANTS 46
4.2.3 STRINGENT REGULATORY GUIDELINES 46
4.3 OPPORTUNITIES 47
4.3.1 RISING REIMBURSEMENT RATES FOR RECONSTRUCTIVE PROCEDURES 47
4.3.2 PRODUCT APPROVAL 48
4.4 CHALLENGES 48
4.4.1 POST-PROCEDURAL COMPLICATIONS 48
4.4.2 PRODUCT RECALLS 49
4.4.3 BREAST AUGMENTATION THROUGH FAT TRANSFER 50
5 PREMIUM INSIGHTS 51
6 GLOBAL BREAST IMPLANTS MARKET, BY TECHNOLOGY 53
6.1 OVERVIEW 54
6.2 INFRAMAMMARY 56
6.3 PERI-AREOLAR 57
6.4 TRANS-AXILLARY 58
6.5 TRANSUMBILICAL 58
7 GLOBAL BREAST IMPLANTS MARKET, BY TYPE 59
7.1 OVERVIEW 60
7.2 SILICONE 62
7.3 SALINE 62
8 GLOBAL BREAST IMPLANTS MARKET, BY SHAPE 64
8.1 OVERVIEW 65
8.2 ROUND IMPLANT SHAPE 67
8.3 ANATOMICAL IMPLANT SHAPE 68
8.4 GUMMY BEAR SHAPE 69
9 GLOBAL BREAST IMPLANTS MARKET, BY SURFACE 70
9.1 OVERVIEW 71
9.2 TEXTURED 73
9.3 SMOOTH 73
10 GLOBAL BREAST IMPLANTS MARKET, BY PLACEMENT 74
10.1 OVERVIEW 75
10.2 SUBPECTORAL INSERTION 77
10.3 SUBGLANDULAR INSERTION 78
10.4 SUBMUSCULAR INSERTION 79
11 GLOBAL BREAST IMPLANTS MARKET, BY SURGERY 80
11.1 OVERVIEW 81
11.2 COSMETIC SURGERY 83
11.3 RECONSTRUCTIVE SURGERY 84
?
12 GLOBAL BREAST IMPLANTS MARKET, BY END USER 85
12.1 OVERVIEW 86
12.2 HOSPITALS 88
12.3 COSMETOLOGY CLINICS 89
13 GLOBAL BREAST IMPLANTS MARKET, BY DISTRIBUTION CHANNEL 90
13.1 OVERVIEW 91
13.2 DIRECT 93
13.3 INDIRECT 93
14 GLOBAL BREAST IMPLANTS MARKET, BY GEOGRAPHY 94
14.1 OVERVIEW 95
14.2 NORTH AMERICA 100
14.2.1 U.S. 105
14.2.2 CANADA 107
14.2.3 MEXICO 109
14.3 EUROPE 111
14.3.1 FRANCE 117
14.3.2 ITALY 119
14.3.3 GERMANY 121
14.3.4 RUSSIA 123
14.3.5 SPAIN 125
14.3.1 UNITED KINGDOM 127
14.3.2 SWITZERLAND 129
14.3.3 NETHERLANDS 131
14.3.4 BELGIUM 133
14.3.5 TURKEY 135
14.3.6 REST OF EUROPE 137
14.4 ASIA-PACIFIC 138
14.4.1 SOUTH KOREA 144
14.4.2 JAPAN 146
14.4.3 CHINA 148
14.4.4 INDIA 150
14.4.5 AUSTRALIA 152
14.4.6 SINGAPORE 154
14.4.7 THAILAND 156
14.4.8 MALAYSIA 158
14.4.9 INDONESIA 160
14.4.10 PHILIPPINES 162
14.4.11 REST OF ASIA-PACIFIC 164
14.5 SOUTH AMERICA 165
14.5.1 BRAZIL 170
14.5.2 REST OF SOUTH AMERICA 172
14.6 MIDDLE EAST & AFRICA 173
14.6.1 SOUTH AFRICA 179
14.6.2 REST OF MIDDLE EAST AND AFRICA 181
15 GLOBAL BREAST IMPLANTS MARKET, COMPANY LANDSCAPE 182
15.1 COMPANY SHARE ANALYSIS: GLOBAL 182
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 183
15.3 COMPANY SHARE ANALYSIS: EUROPE 184
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 185
16 COMPANY PROFILE 186
16.1 ALLERGAN 186
16.1.1 COMPANY SNAPSHOT 186
16.1.2 REVENUE ANALYSIS 186
16.1.3 COMPANY SHARE ANALYSIS 187
16.1.4 PRODUCT PORTFOLIO 187
16.1.5 RECENT DEVELOPMENT 187
16.2 JOHNSON & JOHNSON SERVICES, INC. 188
16.2.1 COMPANY SNAPSHOT 188
16.2.2 REVENUE ANALYSIS 188
16.2.3 COMPANY SHARE ANALYSIS 189
16.2.4 PRODUCT PORTFOLIO 189
16.2.5 RECENT DEVELOPMENT 190
16.3 CEREPLAS 191
16.3.1 COMPANY SNAPSHOT 191
16.3.2 COMPANY SHARE ANALYSIS 191
16.3.3 PRODUCT PORTFOLIO 191
16.3.4 RECENT DEVELOPMENT 191
16.4 GC AESTHETICS 192
16.4.1 COMPANY SNAPSHOT 192
16.4.2 COMPANY SHARE ANALYSIS 192
16.4.3 PRODUCT PORTFOLIO 193
16.4.4 RECENT DEVELOPMENT 194
16.5 ESTABLISHMENT LABS S.A 195
16.5.1 COMPANY SNAPSHOT 195
16.5.2 REVENUE ANALYSIS 195
16.5.3 PRODUCT PORTFOLIO 195
16.5.4 RECENT DEVELOPMENT 196
16.6 SIENTRA, INC 197
16.6.1 COMPANY SNAPSHOT 197
16.6.2 REVENUE ANALYSIS 197
16.6.3 PRODUCT PORTFOLIO 198
16.6.4 RECENT DEVELOPMENTS 198
16.7 DEUTSCHE BETEILIGUNGS AG 199
16.7.1 COMPANY SNAPSHOT 199
16.7.2 REVENUE ANALYSIS 199
16.7.3 PRODUCT PORTFOLIO 200
16.7.4 RECENT DEVELOPMENT 201
16.8 GROUPE SEBBIN SAS 202
16.8.1 COMPANY SNAPSHOT 202
16.8.2 PRODUCT PORTFOLIO 202
16.8.3 RECENT DEVELOPMENT 202
16.9 WANHE 203
16.9.1 COMPANY SNAPSHOT 203
16.9.2 PRODUCT PORTFOLIO 203
16.9.3 RECENT DEVELOPMENT 203
16.10 HANSBIOMED CO. LTD. 204
16.10.1 COMPANY SNAPSHOT 204
16.10.2 PRODUCT PORTFOLIO 204
16.10.3 RECENT DEVELOPMENT 205
16.11 LABORATOIRES ARION 206
16.11.1 COMPANY SNAPSHOT 206
16.11.2 PRODUCT PORTFOLIO 206
16.11.3 RECENT DEVELOPMENT 207
16.12 SHANGHAI KANGNING MEDICAL SUPPLIES LTD. 208
16.12.1 COMPANY SNAPSHOT 208
16.12.2 PRODUCT PORTFOLIO 208
16.12.3 RECENT DEVELOPMENT 210
17 CONCLUSION 211
18 QUESTIONNAIRE 212
19 RELATED REPORTS 215